Cargando…

Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program

INTRODUCTION: In 2020, the COVID-19 pandemic led to significant declines in cancer screening, including among women served by the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). This study examined the spatial association between state-based COVID-19 test percent positivity an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermudez, Yamisha, Scott, Lia C., Beckman, Michele, DeGroff, Amy, Kenney, Kristy, Sun, Juzhong, Rockwell, Tanner, Helsel, William, Kammerer, William, Sheu, Amy, Miller, Jacqueline, Richardson, Lisa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480839/
https://www.ncbi.nlm.nih.gov/pubmed/36108291
http://dx.doi.org/10.5888/pcd19.220111
_version_ 1784791131389689856
author Bermudez, Yamisha
Scott, Lia C.
Beckman, Michele
DeGroff, Amy
Kenney, Kristy
Sun, Juzhong
Rockwell, Tanner
Helsel, William
Kammerer, William
Sheu, Amy
Miller, Jacqueline
Richardson, Lisa C.
author_facet Bermudez, Yamisha
Scott, Lia C.
Beckman, Michele
DeGroff, Amy
Kenney, Kristy
Sun, Juzhong
Rockwell, Tanner
Helsel, William
Kammerer, William
Sheu, Amy
Miller, Jacqueline
Richardson, Lisa C.
author_sort Bermudez, Yamisha
collection PubMed
description INTRODUCTION: In 2020, the COVID-19 pandemic led to significant declines in cancer screening, including among women served by the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). This study examined the spatial association between state-based COVID-19 test percent positivity and proportional change in NBCCEDP screening volume. METHODS: Using the COVID-19 Diagnostic Laboratory Testing dataset, we calculated state-based monthly COVID-19 test percent positivity from July through December 2020 and categorized rates into low, medium, and high groups. We used data from 48 NBCCEDP state awardees to calculate the state-based monthly proportional change in screening volume and compared data for July–December 2020 with the previous 5-year average for those months. We categorized changes in screening volume into large decrease, medium decrease, and minimal change and created maps of the associations between variable subgroups by using bivariate mapping in QGIS. RESULTS: Bivariate relationships between COVID-19 test percent positivity and proportional change in cancer screening volume varied over time and geography. In 5 of 6 months, 4 states had high COVID-19 test percent positivity and minimal change in breast or cervical cancer screening volume; 2 states had high COVID-19 test percent positivity and minimal change in breast and cervical cancer screening volume. CONCLUSION: Some states maintained pre–COVID-19 screening volumes despite high COVID-19 test percent positivity. Follow-up research will be conducted to determine how these states differ from those with consistent decreases in screening volume and identify factors that may have contributed to differences. This information could be useful for planning to maximize NBCCEDP awardees’ ability to maintain screening volume during future public health emergencies.
format Online
Article
Text
id pubmed-9480839
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-94808392022-09-20 Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program Bermudez, Yamisha Scott, Lia C. Beckman, Michele DeGroff, Amy Kenney, Kristy Sun, Juzhong Rockwell, Tanner Helsel, William Kammerer, William Sheu, Amy Miller, Jacqueline Richardson, Lisa C. Prev Chronic Dis Original Research INTRODUCTION: In 2020, the COVID-19 pandemic led to significant declines in cancer screening, including among women served by the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). This study examined the spatial association between state-based COVID-19 test percent positivity and proportional change in NBCCEDP screening volume. METHODS: Using the COVID-19 Diagnostic Laboratory Testing dataset, we calculated state-based monthly COVID-19 test percent positivity from July through December 2020 and categorized rates into low, medium, and high groups. We used data from 48 NBCCEDP state awardees to calculate the state-based monthly proportional change in screening volume and compared data for July–December 2020 with the previous 5-year average for those months. We categorized changes in screening volume into large decrease, medium decrease, and minimal change and created maps of the associations between variable subgroups by using bivariate mapping in QGIS. RESULTS: Bivariate relationships between COVID-19 test percent positivity and proportional change in cancer screening volume varied over time and geography. In 5 of 6 months, 4 states had high COVID-19 test percent positivity and minimal change in breast or cervical cancer screening volume; 2 states had high COVID-19 test percent positivity and minimal change in breast and cervical cancer screening volume. CONCLUSION: Some states maintained pre–COVID-19 screening volumes despite high COVID-19 test percent positivity. Follow-up research will be conducted to determine how these states differ from those with consistent decreases in screening volume and identify factors that may have contributed to differences. This information could be useful for planning to maximize NBCCEDP awardees’ ability to maintain screening volume during future public health emergencies. Centers for Disease Control and Prevention 2022-09-15 /pmc/articles/PMC9480839/ /pubmed/36108291 http://dx.doi.org/10.5888/pcd19.220111 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
Bermudez, Yamisha
Scott, Lia C.
Beckman, Michele
DeGroff, Amy
Kenney, Kristy
Sun, Juzhong
Rockwell, Tanner
Helsel, William
Kammerer, William
Sheu, Amy
Miller, Jacqueline
Richardson, Lisa C.
Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program
title Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program
title_full Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program
title_fullStr Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program
title_full_unstemmed Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program
title_short Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program
title_sort geographic examination of covid-19 test percent positivity and proportional change in cancer screening volume, national breast and cervical cancer early detection program
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480839/
https://www.ncbi.nlm.nih.gov/pubmed/36108291
http://dx.doi.org/10.5888/pcd19.220111
work_keys_str_mv AT bermudezyamisha geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT scottliac geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT beckmanmichele geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT degroffamy geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT kenneykristy geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT sunjuzhong geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT rockwelltanner geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT helselwilliam geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT kammererwilliam geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT sheuamy geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT millerjacqueline geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram
AT richardsonlisac geographicexaminationofcovid19testpercentpositivityandproportionalchangeincancerscreeningvolumenationalbreastandcervicalcancerearlydetectionprogram